Window of opportunity for daclizumab

Nature Medicine

Volumn 17, Issue 5, 2011, Pages 545-547

  Schluns, Kimberly S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA;

ANTIGEN PRESENTING CELL; BINDING AFFINITY; CELL EXPANSION; DENDRITIC CELL; DRUG MECHANISM; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; DENDRITIC CELLS; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; T-LYMPHOCYTES;

EID: 79955695969     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0511-545     Document Type: Note

References (9)

1. Mottershead, M. & Neuberger, J. Expert Opin. Biol. Ther. 7, 1583-1596 (2007).
2. Wang, H.M. & Smith, K.A. J. Exp. Med. 166, 1055-1069 (1987).
3. Wuest, S.C. et al. Nat. Med. 17, 604-609 (2011).
4. Bielekova, B. et al. Proc. Natl. Acad. Sci. USA 103, 5941-5946 (2006).
5. Martin, J.F., Perry, J.S., Jakhete, N.R., Wang, X. & Bielekova, B. J. Immunol. 185, 1311-1320 (2010).
6. Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. J. Exp. Med. 201, 723-735 (2005).
7. Velten, F.W., Rambow, F., Metharom, P. & Goerdt, S. Mol. Immunol. 44, 1544-1550 (2007).
8. Dubois, S., Mariner, J., Waldmann, T.A. & Tagaya, Y. Immunity 17, 537-547 (2002).
9. Granucci, F. et al. Nat. Immunol. 2, 882-888 (2001).